Agenus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.About AGEN
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.
CEOGaro H. Armen
CEOGaro H. Armen
Employees389
Employees389
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded1994
Founded1994
Employees389
Employees389
AGEN Key Statistics
Market cap254.17M
Market cap254.17M
Price-Earnings ratio-0.90
Price-Earnings ratio-0.90
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today$14.04
High today$14.04
Low today$11.90
Low today$11.90
Open price$13.55
Open price$13.55
Volume978.23K
Volume978.23K
52 Week high$42.60
52 Week high$42.60
52 Week low$4.78
52 Week low$4.78
AGEN News
TipRanks 1d
What to Make of Agenus Stock Post Reverse Stock SplitClinical-stage immuno-oncology company Agenus (NASDAQ:AGEN) recently executed a 1-for-20 reverse stock split to give the company greater flexibility in its futu...
TipRanks 2d
Agenus regains compliance with NasdaqAgenus received notice from Nasdaq on April 30, that the company has regained compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listin...